Janus Henderson Group’s EyePoint Pharmaceuticals EYPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-26,700
| Closed | -$156K | – | 2435 |
|
|
2025
Q1 | $156K | Hold |
26,700
| – | – | ﹤0.01% | 2412 |
|
|
2024
Q4 | $199K | Hold |
26,700
| – | – | ﹤0.01% | 2430 |
|
|
2024
Q3 | $213K | Hold |
26,700
| – | – | ﹤0.01% | 2412 |
|
|
2024
Q2 | $232K | Sell |
26,700
-156
| -0.6% | -$1.36K | ﹤0.01% | 2337 |
|
|
2024
Q1 | $555K | Buy |
+26,856
| New | +$555K | ﹤0.01% | 1957 |
|
|
2022
Q4 | – | Sell |
-1,746,868
| Closed | -$13.8M | – | 2470 |
|
|
2022
Q3 | $13.8M | Buy |
1,746,868
+756,832
| +76% | +$5.99M | 0.01% | 761 |
|
|
2022
Q2 | $7.79M | Sell |
990,036
-512,744
| -34% | -$4.04M | 0.01% | 749 |
|
|
2022
Q1 | $18.2M | Sell |
1,502,780
-168,403
| -10% | -$2.04M | 0.01% | 766 |
|
|
2021
Q4 | $20.5M | Buy |
1,671,183
+958,799
| +135% | +$11.7M | 0.01% | 782 |
|
|
2021
Q3 | $7.41M | Buy |
712,384
+47,886
| +7% | +$498K | ﹤0.01% | 962 |
|
|
2021
Q2 | $5.98M | Sell |
664,498
-8,887
| -1% | -$80K | ﹤0.01% | 1026 |
|
|
2021
Q1 | $6.86M | Buy |
673,385
+652,749
| +3,163% | +$6.65M | ﹤0.01% | 961 |
|
|
2020
Q4 | $136K | Buy |
+20,636
| New | +$136K | ﹤0.01% | 1373 |
|